β-cell hyperplasia induced by hepatic insulin resistance: Role of a liver-pancreas endocrine axis through insulin receptor A isoform

Diabetes

Volumn 58, Issue 4, 2009, Pages 820-828

  Escribano, Oscar ^a,b   Guillén, Carlos ^a,b   Nevado, Carmen ^a,b   Gomez Hernández, Almudena ^a,b   Kahn, C Ronald ^c   Benito, Manuel ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR A; SOMATOMEDIN C; UNCLASSIFIED DRUG;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HEPATIC INSULIN RESISTANCE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET CELL HYPERPLASIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; TRANSGENIC MOUSE;

ANIMALS; DIABETES MELLITUS, TYPE 2; EXONS; GENOTYPE; GLUCOSE; GTP-BINDING PROTEINS; HYPERPLASIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN;

EID: 64649097533     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0551     Document Type: Article

References (37)

1. Kahn CR: Banting Lecture: Insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes 43:1066-1084, 1994
2. Kahn CR: Diabetes: causes of insulin resistance. Nature 373:384-385, 1995
3. Nandi A, Kitamura Y, Kahn CR, Accili D: Mouse models of insulin resistance. Physiol Rev 84:623-647, 2004
4. Kitamura T, Kahn CR, Accili A: Insulin receptor knockout mice. Annu Rev Physiol 65:313-332, 2003
5. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal HD: Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109,1996
6. Joshi RL, Lamothe B, Cordonnier N, Mesbah K, Monthioux E, Jami J, Buchini D: Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J 15:1542-1547, 1996
7. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D: Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114:214-223,2004
8. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97, 2000
9. Bruning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Muller-Wieland D, Kahn CR: Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2155, 2000
10. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR: Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339, 1999
11. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569, 1998
12. Kühn R, Schwenk F, Aguet M, Rajewsky K: Inducible gene targeting in mice. Science 269:1427-1429, 1995
13. Valverde AM, Lorenzo M, Pons S, White MF, Benito M: IRS-1 and IRS-2 differential signaling in the insulin/IGF-1 pathways in fetal brown adipo- cytes. Mol Endocrinol 12:688-697, 1998
14. Guerra C, Navarro P, Valverde AM, Arribas M, Bruning J, Kozak LP, Kahn CR, Benito M: Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 108: 1205-1213, 2001
15. Weibel ER: Practical Research Design and Research Design and Methods for Biological Morphometry. London, Academic Press, 1979
16. Bonner-Weir S, Deery D, Leahy JL, Weir GC: Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38:49-53, 1989
17. Guillen C, Navarro P, Robledo M, Valverde AM, Benito M: Differential mitogenic signaling in insulin receptor-deficient fetal pancreatic beta-cells. Endocrinology 147:1959-1968, 2006
18. Nevado C, Benito M, Valverde AM: Role of insulin receptor and balance in insulin receptor isoforms A and B in regulation of apoptosis in simian virus 40-immortalized neonatal hepatocytes. Mol Cell Biol 19:1185-1198, 2008
19. Escribano O, Arribas M, Valverde AM, Benito M: IRS-3 mediates insulin- induced glucose uptake in differentiated IRS-2(-/-) brown adipocytes. Mol Cell Endocrinol 30:1-9, 2007
20. Escribano O, Fernandez-Moreno MD, Zueco JA, Menor C, Fueyo J, Ropero RM, Diaz-Laviada I, Román ID, Guijarro LG: Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver. Hepatology 37:1461-1469, 2003
21. Flier SN, Kulkarni RN, Kahn CR: Evidence for a circulating islet cell growth factor in insulin-resistant status. Proc Natl Acad Sci U S A 98:7475-7480,2001
22. McClain DA: Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 5:734-739, 1991
23. Kitamura T, Kitamura Y, Nakae J, Giordano A, Cinti S, Kahn CR, Efstra- tiadis A, Accili D: Mosaic analysis of insulin receptor function. J Clin Invest 113:209-219, 2004
24. Buettner C, Patel R, Muse ED, Bhanot S, Monia BP, McKay R, Obici S, Rossetti L: Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J Clin Invest 115:1306-1313, 2005
25. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. Endocr Rev 19:608-624, 1998
26. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904, 1998
27. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krutzfeld J, Yin C,Holzember M, Stoffel M, Kulkarni RN: Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci U S A 104:8977-8982, 2007
28. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, Leroith D: Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110:771-781, 2002
29. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR: β-Cell-specific deletion of the Igf1 receptor leads to hyperinsu- linemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115, 2002
30. Schneider MR, Lahm H, Wu M, Hoeflich A, Wolf E: Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 14:629-640, 2000
31. Guo S, Rena G, Cichy S, He X, Cohen P, Unterman T: Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J Biol Chem 274:17184-17192, 1999
32. Gay E, Seurin D, Babajko S, Doublier S, Cazillis M, Binoux M: Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 138:2937-2947, 1997
33. Rajkumar K, Barron D, Lewitt MS, Murphy LJ: Growth retardation and hyperglycemia in insulin like growth factor binding protein-1 transgenic mice. Endocrinology 136:4029-4034, 1995
34. Rajkumar K, Dheen ST, Murphy LJ: Hyperglycemia and impaired glucose tolerance in insulin-like growth factor binding protein-1 transgenic mice. Am J Physiol 270:E565-E571, 1996
35. Rajkumar K, Krsek M, Dheen ST, Murphy LJ: Impaired glucose homeosta- sis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98:1818-1825, 1996
36. Dheen ST, Rajkumar K, Murphy LJ: Islet cell proliferation and apoptosis in insulin-like growth factor binding protein-1 in transgenic mice. J Endocri- nol 155:551-558, 1997
37. Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF: Inactivation of hepatic foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65-76,2008